Evidence map›Paper›PMID 38855596›Full record

ReviewTranslational andrology and urology2024

Artificial urinary sphincter erosion and infection: a contemporary review of perioperative considerations and management.

Tej J Desai, Alexander T Rozanski

Abstract readReview
In one paragraph

Review in Translational andrology and urology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Tej J DesaiDepartment of Urology, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.ORCID https://orcid.org/0000-0002-1634-425X
Alexander T RozanskiDepartment of Urology, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Surgical treatment options have long been a part of the treatment armamentarium in the field of male stress urinary incontinence (SUI) and will continue to play an important role moving forward given the dramatic improvement they can have on a patient's quality of life and urinary tract function and control. The artificial urinary sphincter (AUS) is widely considered the gold standard treatment option for male SUI given its breadth of effectiveness in mild, moderate, and severe cases of SUI. As with any surgery, there are potential perioperative risks and complications that all patients must be aware of when weighing the pros and cons of different treatment options. Two of the most dreaded complications of AUS surgery are urethral cuff erosion and device infection, both necessitating a subsequent surgery for device explant. The goal of this clinical practice review article is to examine and discuss the perioperative factors and management of these complications. Effectively treating these complications is of utmost importance, not just to address the acute clinical problem for patient health and safety, but also to provide the patient with the best chance of pursuing AUS replacement surgery in the future, given that the vast majority of these patients will develop recurrent bothersome SUI after the eroded and/or infected device is removed. By reviewing pertinent patient factors, preoperative and postoperative considerations, device-specific characteristics, surgical techniques, and patient counseling, this article serves as a thorough and practical clinical review guide for practicing urologists who perform male incontinence surgery.

Indexed as

Artificial urinary sphincter (AUS)erosioninfection

Identifiers

PMID38855596
PMCPMC11157387

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.